LANXESS signs contract to acquire Microbial Control business of IFF

Ad hoc according to Art. 17 paragraph 1 MMVO

Cologne, August 23, 2021 – Specialty chemicals company LANXESS has signed an agreement to acquire the microbial control business from the US-based company International Flavors & Fragrances Inc. (IFF). The acquisition will create one of the leading global suppliers of biocides.

The microbial control business comprises two production sites in the US and  approximately 270 employees worldwide. Sales amount to around USD 450 million* with EBITDA pre exceptionals approximating USD 100 million*. Around 75 percent of sales are generated in America and Asia.

For the transaction with an enterprise value of USD 1.3 billion LANXESS has secured bridge financing which is expected to be refinanced with senior corporate bonds.

Closing of the transaction is expected in the second quarter of 2022 and among other items subject to the approval of the relevant regulatory authorities. In addition, the microbial control business has to be carved-out by IFF.

By acquiring the IFF microbial control business, LANXESS strengthens its specialty chemicals portfolio in the Consumer Protection segment and materially expands its growth businesses disinfection, home & personal care and material preservation.

With the recent acquisitions, LANXESS has created attractive growth opportunities and is now re-prioritizing its capital allocation priorities. Against this background, the currently suspended share buy-back program in the amount of EUR 463 million will be terminated. The approximately 1.1 million repurchased shares under the program will be cancelled.

Cologne, August 23, 2021

* on a normalized level, meaning in an average year

Information for editors:
All LANXESS news releases and their accompanying photos can be found at
Recent photos of the Board of Management and other LANXESS image material are available at

You can find further information concerning LANXESS chemistry in our digital magazine “Inside LANXESS” at




LANXESS signs contract to acquire Microbial Control business of IFF

August 23, 2021

LANXESS signs contract to acquire Emerald Kalama Chemical

February 14, 2021

LANXESS EBITDA pre exceptionals for fourth quarter 2020 estimated above market expectations

January 26, 2021

LANXESS suspends share buy-back

April 06, 2020

LANXESS decides on share buy-back program with a total volume of up to EUR 500 million

March 10, 2020
Usage of Cookies
We would like to use cookies to better understand you use of this website. This enables us to improve your future experience on our website. Detailed information about the use of cookies on this website and how you can manage or withdraw your consent at any time can be found in our Privacy Statement.

OK Other Settings